Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Cardiorenal Medicine

Guidelines for Authors
www.karger.com/crm_guidelines

Submission
Conditions
Types of Articles
Peer-Review Policy
Conflict of Interest
Ethics
Plagiarism Policy
Arrangement
Color Illustrations
References
Digital Object Identifier (DOI)
Supplementary Material
Self-Archiving/Green Open Access, Author's ChoiceTM,
   Funding Organizations (NIH etc.)

Page charges
Proofs
Reprints


Submission

'CardioRenal Medicine' only accepts online submissions.
Please also consult the general Technical Instructions page on the preparation of manuscripts and figures.



Conditions

The journal will not publish articles which have been previously reported at any length or articles being considered for publication elsewhere. The authors must include a statement to this effect in their cover letter. If publication of the data in any form has occurred or is being contemplated, a copy of such publication should be included with the submitted manuscript.

Submission of an article for publication implies the transfer of the copyright from the author to the publisher upon acceptance.

For legal reasons, we must receive your 'Submission Statement' with your original (hand-written) signature. Please download, print, sign and either fax or scan it to make it legally binding.

It is the author's responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.

The manuscript should be written in English and the editors reserve the right to make appropriate corrections in grammar and style.

Accepted papers become the permanent property of 'CardioRenal Medicine' and may not be reproduced by any means, in whole or in part, without the written consent of the publisher.

Information concerning financial disclosures (i.e. grants, funding, support, etc.) should be placed at the foot of the title page.



Types of Articles for Acceptance

1. Original Papers: Representing full sets of completed experiments in the areas of either clinical or basic research that answer a given question. Max. 3,000 words, incl. figures, tables. Maximum 25 references.

2. Reviews: Covering a timely topic by experts in the field. An Abstract is required and should be divided into Background, Summary and Key Messages. Max. 4,500 words, incl. figures, tables. Maximum 60 references.



Peer-Review Policy

'CardioRenal Medicine' is a peer-reviewed journal that uses a single blind peer-review. Our aim is to provide authors with fast and constructive feedback regarding their submitted manuscript. The Editor-in-Chief and the international Editorial Board ensure a thorough and fair peer-review and the highest scientific publishing standards. Submitted manuscripts are checked by the Editorial Office and forwarded to the Editor-in-Chief, who decides whether to accept/reject or send the manuscript for review to at least two reviewers that can be members of the Editorial Board or external reviewers. Reviewers must have a recent publication record in the area of the submission, must not have published with the authors in the previous three years, and must not be from the same institution as the authors. The Editor-in-Chief makes a final decision on all papers submitted to the journal and is responsible to maintain high quality peer-review.



Conflict of Interest

Authors are required to disclose any financial (funding, stocks, patents, employment, honoraria, royalties) or non-financial (political, personal, professional) interests/relationships that may be interpreted to have influenced the manuscript. Conflicts of Interest Statements will be published at the end of the manuscript. If there is no conflict of interest, please state "The authors declare no conflicts of interest".



Ethics

Published research must comply with the guidelines for human studies and animal welfare regulations. Manuscripts reporting studies on human subjects should include evidence that the research was ethically conducted in accordance with the World Medical Association Declaration of Helsinki. In particular, authors must provide a 'Statement of Ethics' at the end of the manuscript and declare that subjects (or their parents or guardians) have given their informed written consent and that the study protocol was approved by an appropriate ethics committee. If no approval was required, this must be stated in this section. All patients should be identified by numbers or aliases, not by their real names. For clinical trials, registration in a public trials registry at or before the time of first patient enrollment is a condition of consideration for publication. The trial registration number must be provided upon submission. Authors should also state that animal experimentation was approved by the appropriate institutional review body. Copies of these guidelines and policy statements must be available for review by the editors if necessary. Authors are encouraged to follow the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines for reporting on animal studies.



Plagiarism Policy

Plagiarism PolicyWhether intentional or not, plagiarism is a serious violation. We define a case of plagiarism if there is 25% similarity in the Results or Discussion that exactly reproduces another paper without citation.
If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s).



Arrangement

Title page: The first page of each paper should indicate the title, the authors' names, the institute where the work was conducted, a short title for use as running head, conflict of interest statement, and word count. Manuscripts are to be double-spaced and formatted using the same font, size 12 throughout text and references.

Full address: The exact postal address of the corresponding author complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as e-mail address.

Key words: Please supply 3–10 key words in English that reflect the content of the paper.

Abstract of Original Papers: Each paper needs an abstract of up to 250 words. Except for reviews, abstracts should be structured as follows:
   Background/Aims: What is the major problem that prompted the study?
   Methods: How was the study performed?
   Results: Most important findings?
   Conclusion: Most important conclusion?

Abstract of Reviews: Should be divided into the following subsections: Background, Summary and Key Messages. The Background should provide a brief clinical context for the review and is followed by the Summary, which should include a concise description of the main topics covered in the text. The Key Messages encapsulate the main conclusions of the review.

Footnotes: Avoid footnotes.

Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be prepared on separate pages. Tables require a heading and figures a legend, also prepared on a separate page. Electronically submitted b/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800–1,200 dpi. Average table = 250 words.

The maximum size of all uploaded files is 40 Mb.



Color Illustrations

Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text and figure legends.

Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF 960.– per page.



References

In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as 'unpublished data' and not be included in the reference list. The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, cite all authors. Abbreviate journal names according to the Index Medicus system. (Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals (www.icmje.org).

Examples

(a) Papers published in periodicals: Chatel J-M, Bernard H, Orson FM: Isolation and characterization of two complete Ara h 2 isoforms cDNA. Int Arch Allergy Immunol 2003;131:14–18.

(b) Papers published only with DOI numbers: Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858.

(c) Monographs: Matthews DE, Farewell VT: Using and Understanding Medical Statistics, ed 4, revised. Basel, Karger, 2007.

(d) Edited books: DuBois RN: Cyclooxygenase-2 and colorectal cancer; in Dannenberg AJ, Dubois RN (eds): COX-2. Prog Exp Tum Res. Basel, Karger, 2003, vol 37, pp 124–137.

Reference Management Software: Use of EndNote® is recommended for easy management and formatting of citations and reference lists.



Digital Object Identifier (DOI)

S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org.



Supplementary Material

Multimedia files and other supplementary files, directly relevant but not essential to the conclusions of a paper, enhance the online version of a publication and increase its visibility on the web. These files will undergo editorial review. The Editors reserve the right to limit the scope and length of the supplementary material. Multimedia and supplementary material should meet production quality standards for publication without the need for any modification or editing. Files should not exceed 10 MB in size. Figures and tables need to have titles and legends, and all files should be supplied separately and labeled clearly. All supplementary material should be referred to in the main text. A DOI number will be assigned to supplementary material and it will be hosted online at https://karger.figshare.com under a CC BY license. Authors will be charged a processing fee of CHF 250.00 for supplementary material.



Self-Archiving/Green Open Access

Karger permits authors to archive their pre-prints (i.e. pre-peer review) or post-prints (i.e. accepted manuscript after peer review but before production) on their personal or their institution’s internal website. In addition, authors may post their accepted manuscripts in public Open Access repositories and scientific networks (e.g. ResearchGate or Mendeley) no earlier than 12 months following publication of the final version of their article. For all self-archiving, the posted manuscripts must:

  • Be used for noncommercial purposes only
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘This is the peer-reviewed but unedited manuscript version of the following article: [insert full citation, e.g. Cytogenet Genome Res 2014;142:227–238 (DOI: 10.1159/000361001)]. The final, published version is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.

Manuscripts to be archived in PubMed Central due to funding requirements will be submitted by Karger on the author’s behalf [see Funding Organizations (NIH etc.)].

For self-archiving Author's ChoiceTM (Gold Open Access) articles, see Author's ChoiceTM.


Author's ChoiceTM

Karger’s Author's ChoiceTM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.karger.com. The option is available for a one-time fee of CHF 3,000.00, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice.
The final, published version of the article may be posted at any time and in any repository or on other websites, in accordance with the relevant Creative Commons license. Reposted Open Access articles must:

  • Follow the terms of the relevant Creative Commons license
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘The final, published version of this article is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.


Funding Organizations (NIH etc.)

The U.S. National Institutes of Health (NIH) Public Access Policy mandates that accepted, peer-reviewed manuscripts are archived in its digital database, PubMed Central (PMC), within 12 months of the official publication date. As a service to authors, Karger submits NIH-funded articles to PMC on behalf of the authors immediately upon publication. The NIH assigns a PMCID within approximately 1 month and the manuscript will appear in PMC after a 12-month embargo. For authors making their paper Open Access through Author's ChoiceTM, the embargo will be overridden, thereby accelerating the accessibility of the article. Karger also complies with other funders’ requirements (including Wellcome Trust and RCUK) for submission to PMC.
Authors should include information on their grant in the Acknowledgements section of their papers.



Page charges

There are no page charges for papers of 4 printed pages. Each additional complete or partial page will be charged to the author at the rate of CHF 325.00 per page.



Proofs

Unless indicated otherwise, proofs are sent to the first-named author and should be returned with the least possible delay. Alterations made in proofs, other than the correction of printer's errors, are charged to the author.



Reprints

Order forms and a price list are sent with the proofs. Orders submitted after the issue is printed are subject to considerably higher prices.